INSURANEWS Logo
Top Stories
Life
Health
Medicare
Property & Casualty
Annuity
Industry

CVS Health Plans Major Split into Two Companies by 2028

Share:

In a significant move aimed at improving healthcare delivery, CVS Health has announced plans to split into two distinct publicly traded companies beginning in 2028.

On November 4, 2026, CVS Health's board of directors unveiled the strategic decision to divide the company, emphasizing the goals of affordability, accessibility, and simplicity in healthcare services. The separation will give rise to CVS Health as a standalone healthcare solutions provider while CVS Pharmacy takes form as an independent retail entity. This decision underscores CVS Health’s commitment to adapting dynamically to evolving healthcare challenges and optimizing service delivery for consumers.

Leadership and Strategic Focus

David Joyner, currently the Chairman and CEO of CVS Health, will lead the new healthcare solutions company. Meanwhile, Prem Shah, Group President, will helm the newly independent CVS Pharmacy as CEO. This organizational transformation reflects a significant shift in focus, with CVS Health poised to deliver integrated healthcare solutions through its subsidiaries like Aetna, CVS Caremark, and CVS Specialty. Meanwhile, CVS Pharmacy will continue its role as a top-tier retail pharmacy, striving to enhance patient care through expanded partnerships and technological innovations.

Implications for the Insurance Industry

This restructuring could have profound implications for the insurance industry, especially concerning coverage, claims management, and consumer access. By leveraging technological advancements like Health100, the aim is to tackle modern healthcare challenges such as escalating costs and limited access. For insurance professionals, the split signals potential changes in the integration of care coordination and member engagement. As both companies plan to maintain strong investment-grade ratings, the separation could prompt new dynamics in risk management, investment strategies, and competitive positioning in the healthcare sector.

Future Prospects and Investor Assurance

CVS Health has articulated a seamless transition strategy, ensuring that clients and customers experience uninterrupted services. The separation has been structured as a tax-free event for U.S. federal income tax purposes, with shareholders retaining equity in both of the new companies. Financial advisors Goldman Sachs & Co. LLC and Consello, alongside legal counsel from Wachtell, Lipton, Rosen & Katz, are overseeing the separation, aiming for completion in the first half of 2028. CVS Health has organized an investor call to elaborate on the separation, with a webcast available for a year, emphasizing transparency and investor engagement throughout this transformative period.

Key Points of CVS Health's Strategic Split

  • Separation into two public companies: CVS Health and CVS Pharmacy.
  • Strategic aim: Enhance affordability, accessibility, and simplicity in healthcare.
  • Leadership: David Joyner for CVS Health; Prem Shah for CVS Pharmacy.
  • Technology focus: Adoption of innovations like Health100 to address cost and access issues.
  • Financial strategy: Execution as a tax-free event, targeting completion by 2028.

With approximately 9,000 retail pharmacies and over 1,000 clinics, CVS Health's commitment to enhancing healthcare delivery continues unabated, promising significant opportunities and challenges for insurance professionals navigating this critical phase in healthcare evolution.